Boulding Mark Elliott's Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Jun 22, 2026
- Accession no.
- 0001578852-26-000018
- Filed
- Jun 22, 2026
- Trade date
- Jun 17, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $822.9K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Boulding Mark ElliottCIK 0001578852 | Officer (EXEC. VP AND CLO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Common Stock | MOption exerciseAcquired | +8,510 | $46.54 | +$396,055.4 | 113,722 | Direct | |
| Jun 17, 2026 | Common Stock | SSaleDisposed | −6,600 | $78.50F2 | −$518,100 | 107,122 | Direct | |
| Jun 17, 2026 | Common Stock | SSaleDisposed | −1,850 | $79.24F3 | −$146,594 | 105,272 | Direct | |
| Jun 17, 2026 | Common Stock | MOption exerciseAcquired | +2,012 | $46.54 | +$93,638.48 | 107,284 | Direct | |
| Jun 17, 2026 | Common Stock | SSaleDisposed | −1,703 | $78.50F2 | −$133,685.5 | 105,581 | Direct | |
| Jun 17, 2026 | Common Stock | SSaleDisposed | −309 | $79.25F4 | −$24,488.25 | 105,272 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Common Stock | MOption exerciseDisposed | −8,510 | $0.00 | $0 | 32,950 | Direct | |
| Jun 17, 2026 | Common Stock | MOption exerciseDisposed | −2,012 | $0.00 | $0 | 30,938 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $78.00 to $78.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 2 transactions in Table I.
- F3
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $79.00 to $79.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $79.00 to $79.48 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.